Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease

被引:195
作者
Rogers, J [1 ]
Lue, LF [1 ]
机构
[1] Sun Hlth Res Inst, LJ Roberts Ctr Alzheimers Res, Sun City, AZ 85372 USA
关键词
microglial chemotaxis; amyloid beta-peptide; Alzheimer's disease;
D O I
10.1016/S0197-0186(01)00040-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Microglia are widely held to play important pathophysiologic roles in Alzheimer's disease (AD). On exposure to amyloid beta peptide (AP) they exhibit chemotactic. phagocytic, phenotypic and secretory responses consistent with scavenger cell activity in a localized inflammatory setting. Because AD microglial chemotaxis, phagocytosis, and secretory activity have common, tightly linked soluble intermediaries (e.g., cytokines, chemokines), cell surface intermediaries (e.g., receptors, opsonins), and stimuli (e.g., highly inert AP deposits and exposed neurofibrilly tangles), the mechanisms for microglial clearance of AP are necessarily coupled to localized inflammatory mechanisms that can be cytotoxic to nearby tissue. This presents a critical dilemma for strategies to remove AP by enhancing micoglial activation-a dilemma that warrants substantial further investigation. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:333 / 340
页数:8
相关论文
共 65 条
[1]   Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein [J].
Akiyama, H ;
Schwab, C ;
Kondo, H ;
Mori, H ;
Kametani, F ;
Ikeda, K ;
McGeer, PL .
NEUROSCIENCE LETTERS, 1996, 206 (2-3) :169-172
[2]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[3]  
Ard MD, 1996, J NEUROSCI RES, V43, P190, DOI 10.1002/(SICI)1097-4547(19960115)43:2<190::AID-JNR7>3.0.CO
[4]  
2-B
[5]   EARLY AND RAPID DE-NOVO SYNTHESIS OF ALZHEIMER BETA-A4-AMYLOID PRECURSOR PROTEIN (APP) IN ACTIVATED MICROGLIA [J].
BANATI, RB ;
GEHRMANN, J ;
CZECH, C ;
MONNING, U ;
JONES, LL ;
KONIG, G ;
BEYREUTHER, K ;
KREUTZBERG, GW .
GLIA, 1993, 9 (03) :199-210
[6]   Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].
Bard, F ;
Cannon, C ;
Barbour, R ;
Burke, RL ;
Games, D ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Lieberburg, I ;
Motter, R ;
Nguyen, M ;
Soriano, F ;
Vasquez, N ;
Weiss, K ;
Welch, B ;
Seubert, P ;
Schenk, D ;
Yednock, T .
NATURE MEDICINE, 2000, 6 (08) :916-919
[7]   A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease [J].
Chen, GQ ;
Chen, KS ;
Knox, J ;
Inglis, J ;
Bernard, A ;
Martin, SJ ;
Justice, A ;
McConlogue, L ;
Games, D ;
Freedman, SB ;
Morris, RGM .
NATURE, 2000, 408 (6815) :975-979
[8]   Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid β-peptide by microglial cells [J].
Chung, HY ;
Brazil, MI ;
Soe, TT ;
Maxfield, FR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :32301-32308
[9]   THE AMYLOID BETA-PROTEIN OF ALZHEIMERS-DISEASE IS CHEMOTACTIC FOR MONONUCLEAR PHAGOCYTES [J].
DAVIS, JB ;
MCMURRAY, HF ;
SCHUBERT, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (02) :1096-1100
[10]  
Ding MZ, 1997, J BIOL CHEM, V272, P11327